Bropirimine in bladder cancer: clinical studies.
Sarosdy
M F
MF
Division of Urology, University of Texas Health Science Center, San Antonio 78284-7845.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use; D002278:Carcinoma in Situ / Q000188:drug therapy*; D003596:Cytosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D003596:Cytosine; C033560:bropirimine